Indie Asset Partners, LLC Merck & Co., Inc. Transaction History

Indie Asset Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$70.31 - $77.77 $187,798 - $207,723	-2,671 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$71.77 - $79.65 $18,803 - $20,868	-262 Reduced 8.93%	2,671 $218,000
Q2 2020 Aug 12, 2020	SELL	$70.42 - $80.13 $86,616 - $98,559	-1,230 Reduced 29.55%	2,933 $237,000
Q1 2020 May 13, 2020	BUY	$63.36 - $87.82 $263,767 - $365,594	4,163 New	4,163 $320,000

3,831

1.91B

13.4M

10.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $288B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Indie Asset Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Indie Asset Partners, LLC with notifications on news.